Neuralink says the FDA designated its Blindsight implant as a ‘breakthrough device’
Neuralink says the Food and Drug Administration has designated its experimental Blindsight implant as a “breakthrough device.” The company is developing the technology in an attempt to restore blind people’s sight.
Manufacturers who apply to the FDA’s …